Use of medetomidine and ketamine for immobilization of free-ranging giraffes

Mitchell Bush, Douw G. Grobler, Jacobus P. Raath, Lyndsay Phillips, M. Andrew Stamper, William R. Lance

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective - To develop a dosage correlated with shoulder height (SH) in centimeters for effective immobilization of free-ranging giraffes, using a combination of medetomidine (MED) and ketamine (KET) and reversal with atipamezole (ATP). Design - Prospective study. Animals - 23 free-ranging giraffes. Procedure - The drug combination (MED and KET) was administered by use of a projectile dart. Quality of induction, quality of immobilization, and time to recovery following injection of ATP were evaluated. Physiologic variables measured during immobilization included PaO2, PaCO2, oxygen saturation, end-tidal CO2, blood pH, indirect arterial blood pressure, heart and respiratory rates, and rectal temperature. Results - Sixteen giraffes became recumbent with a dosage (mean ± SD) of 143 ± 29 μg of MED and 2.7 ± 0.6 mg of KET/cm of SH. Initially, giraffes were atactic and progressed to lateral recumbency. Three giraffes required casting with ropes for data collection, with dosages of 166 ± 5 μg of MED and 3.2 ± 0.6 mg of KET/cm of SH. Four giraffes required administration of etorphine (n = 2) or were cast with ropes (2) for capture but remained dangerous to personnel once recumbent, precluding data collection. In giraffes successfully immobilized, physiologic monitoring revealed hypoxia and increased respiratory rates. Values for PaCO2, end-tidal CO2, and heart rate remained within reference ranges. All giraffes were hypertensive and had a slight increase in rectal temperature. Atipamezole was administered at 340 ± 20 μg/cm of SH, resulting in rapid and smooth recoveries. Conclusions and Clinical Relevance - Medetomidine and KET was an effective immobilizing combination for free-ranging giraffes; however, at the dosages used, it does not induce adequate analgesia for major manipulative procedures. Quality of induction and immobilization were enhanced if the giraffe was calm. Reversal was rapid and complete following injection of ATP.

Original languageEnglish (US)
Pages (from-to)245-249
Number of pages5
JournalJournal of the American Veterinary Medical Association
Volume218
Issue number2
DOIs
StatePublished - Jan 15 2001

Fingerprint

Medetomidine
Giraffa camelopardalis
medetomidine
Ketamine
ketamine
Immobilization
shoulders
ropes
Respiratory Rate
dosage
respiratory rate
heart rate
Heart Rate
Etorphine
etorphine
Giraffes
injection
combination drug therapy
Injections
Temperature

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Use of medetomidine and ketamine for immobilization of free-ranging giraffes. / Bush, Mitchell; Grobler, Douw G.; Raath, Jacobus P.; Phillips, Lyndsay; Stamper, M. Andrew; Lance, William R.

In: Journal of the American Veterinary Medical Association, Vol. 218, No. 2, 15.01.2001, p. 245-249.

Research output: Contribution to journalArticle

Bush, Mitchell ; Grobler, Douw G. ; Raath, Jacobus P. ; Phillips, Lyndsay ; Stamper, M. Andrew ; Lance, William R. / Use of medetomidine and ketamine for immobilization of free-ranging giraffes. In: Journal of the American Veterinary Medical Association. 2001 ; Vol. 218, No. 2. pp. 245-249.
@article{9c0eb9a15b86495b8c357d21322e7a84,
title = "Use of medetomidine and ketamine for immobilization of free-ranging giraffes",
abstract = "Objective - To develop a dosage correlated with shoulder height (SH) in centimeters for effective immobilization of free-ranging giraffes, using a combination of medetomidine (MED) and ketamine (KET) and reversal with atipamezole (ATP). Design - Prospective study. Animals - 23 free-ranging giraffes. Procedure - The drug combination (MED and KET) was administered by use of a projectile dart. Quality of induction, quality of immobilization, and time to recovery following injection of ATP were evaluated. Physiologic variables measured during immobilization included PaO2, PaCO2, oxygen saturation, end-tidal CO2, blood pH, indirect arterial blood pressure, heart and respiratory rates, and rectal temperature. Results - Sixteen giraffes became recumbent with a dosage (mean ± SD) of 143 ± 29 μg of MED and 2.7 ± 0.6 mg of KET/cm of SH. Initially, giraffes were atactic and progressed to lateral recumbency. Three giraffes required casting with ropes for data collection, with dosages of 166 ± 5 μg of MED and 3.2 ± 0.6 mg of KET/cm of SH. Four giraffes required administration of etorphine (n = 2) or were cast with ropes (2) for capture but remained dangerous to personnel once recumbent, precluding data collection. In giraffes successfully immobilized, physiologic monitoring revealed hypoxia and increased respiratory rates. Values for PaCO2, end-tidal CO2, and heart rate remained within reference ranges. All giraffes were hypertensive and had a slight increase in rectal temperature. Atipamezole was administered at 340 ± 20 μg/cm of SH, resulting in rapid and smooth recoveries. Conclusions and Clinical Relevance - Medetomidine and KET was an effective immobilizing combination for free-ranging giraffes; however, at the dosages used, it does not induce adequate analgesia for major manipulative procedures. Quality of induction and immobilization were enhanced if the giraffe was calm. Reversal was rapid and complete following injection of ATP.",
author = "Mitchell Bush and Grobler, {Douw G.} and Raath, {Jacobus P.} and Lyndsay Phillips and Stamper, {M. Andrew} and Lance, {William R.}",
year = "2001",
month = "1",
day = "15",
doi = "10.2460/javma.2001.218.245",
language = "English (US)",
volume = "218",
pages = "245--249",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "2",

}

TY - JOUR

T1 - Use of medetomidine and ketamine for immobilization of free-ranging giraffes

AU - Bush, Mitchell

AU - Grobler, Douw G.

AU - Raath, Jacobus P.

AU - Phillips, Lyndsay

AU - Stamper, M. Andrew

AU - Lance, William R.

PY - 2001/1/15

Y1 - 2001/1/15

N2 - Objective - To develop a dosage correlated with shoulder height (SH) in centimeters for effective immobilization of free-ranging giraffes, using a combination of medetomidine (MED) and ketamine (KET) and reversal with atipamezole (ATP). Design - Prospective study. Animals - 23 free-ranging giraffes. Procedure - The drug combination (MED and KET) was administered by use of a projectile dart. Quality of induction, quality of immobilization, and time to recovery following injection of ATP were evaluated. Physiologic variables measured during immobilization included PaO2, PaCO2, oxygen saturation, end-tidal CO2, blood pH, indirect arterial blood pressure, heart and respiratory rates, and rectal temperature. Results - Sixteen giraffes became recumbent with a dosage (mean ± SD) of 143 ± 29 μg of MED and 2.7 ± 0.6 mg of KET/cm of SH. Initially, giraffes were atactic and progressed to lateral recumbency. Three giraffes required casting with ropes for data collection, with dosages of 166 ± 5 μg of MED and 3.2 ± 0.6 mg of KET/cm of SH. Four giraffes required administration of etorphine (n = 2) or were cast with ropes (2) for capture but remained dangerous to personnel once recumbent, precluding data collection. In giraffes successfully immobilized, physiologic monitoring revealed hypoxia and increased respiratory rates. Values for PaCO2, end-tidal CO2, and heart rate remained within reference ranges. All giraffes were hypertensive and had a slight increase in rectal temperature. Atipamezole was administered at 340 ± 20 μg/cm of SH, resulting in rapid and smooth recoveries. Conclusions and Clinical Relevance - Medetomidine and KET was an effective immobilizing combination for free-ranging giraffes; however, at the dosages used, it does not induce adequate analgesia for major manipulative procedures. Quality of induction and immobilization were enhanced if the giraffe was calm. Reversal was rapid and complete following injection of ATP.

AB - Objective - To develop a dosage correlated with shoulder height (SH) in centimeters for effective immobilization of free-ranging giraffes, using a combination of medetomidine (MED) and ketamine (KET) and reversal with atipamezole (ATP). Design - Prospective study. Animals - 23 free-ranging giraffes. Procedure - The drug combination (MED and KET) was administered by use of a projectile dart. Quality of induction, quality of immobilization, and time to recovery following injection of ATP were evaluated. Physiologic variables measured during immobilization included PaO2, PaCO2, oxygen saturation, end-tidal CO2, blood pH, indirect arterial blood pressure, heart and respiratory rates, and rectal temperature. Results - Sixteen giraffes became recumbent with a dosage (mean ± SD) of 143 ± 29 μg of MED and 2.7 ± 0.6 mg of KET/cm of SH. Initially, giraffes were atactic and progressed to lateral recumbency. Three giraffes required casting with ropes for data collection, with dosages of 166 ± 5 μg of MED and 3.2 ± 0.6 mg of KET/cm of SH. Four giraffes required administration of etorphine (n = 2) or were cast with ropes (2) for capture but remained dangerous to personnel once recumbent, precluding data collection. In giraffes successfully immobilized, physiologic monitoring revealed hypoxia and increased respiratory rates. Values for PaCO2, end-tidal CO2, and heart rate remained within reference ranges. All giraffes were hypertensive and had a slight increase in rectal temperature. Atipamezole was administered at 340 ± 20 μg/cm of SH, resulting in rapid and smooth recoveries. Conclusions and Clinical Relevance - Medetomidine and KET was an effective immobilizing combination for free-ranging giraffes; however, at the dosages used, it does not induce adequate analgesia for major manipulative procedures. Quality of induction and immobilization were enhanced if the giraffe was calm. Reversal was rapid and complete following injection of ATP.

UR - http://www.scopus.com/inward/record.url?scp=0035863812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035863812&partnerID=8YFLogxK

U2 - 10.2460/javma.2001.218.245

DO - 10.2460/javma.2001.218.245

M3 - Article

VL - 218

SP - 245

EP - 249

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 2

ER -